A study found that, utilizing cell-free DNA sequencing leveraging methylation patterns, a new blood test could detect more than 50 cancer types and the location of these cancer types in the body.
In a webinar hosted by the American Nurses Association, Terri Rebmann, PhD, RN, CIC, FAPIC, discussed how nurses can protect themselves and their patients during the COVID-19 pandemic.
Clinicians advised the best approaches for treating patients who have been diagnosed or are currently under treatment for cancer during the ongoing COVID-19 pandemic.
Researchers reported updated findings of infigratinib in upper tract urothelial carcinoma and urothelial carcinoma of the bladder, supporting the development of phase III studies in this setting.
Immutep reported positive data from the randomized phase IIb AIPAC clinical trial of eftilagimod alpha and paclitaxel in HER2-negative, HR-positive metastatic breast cancer (MBC).
In a podcast, published by The New England Journal of Medicine (NEJM), physicians discuss practical measures that could help prevent the coronavirus disease 2019 (COVID-19).
The deputy director at NYU Langone’s Perlmutter Cancer Center explained the importance of these agents and the development of clinical trials in this setting.
Plastic surgeon and breast specialist Dr. Constance Chen discussed the potential complications of implant-based breast reconstruction, and how it compares to natural tissue reconstruction.
ASCO released new guidelines for treating patients with late-stage colorectal cancer based on previously existing guidelines using an expert panel.
The American College of Surgeons released guidelines for triaging surgeries of patients with cancer during the COVID-19 pandemic.
Researchers found that patients with cancer demonstrated deteriorating conditions and poor outcomes from the COVID-19 infection.
Researchers determined that artificial intelligence could help predict responses to systemic therapies for patients with non-small cell lung cancer by utilizing CT scans.
A recent study analyzed response to treatment of oligometastatic prostate cancer with stereotactic ablative radiotherapy and found improved oncologic outcomes among men.
Researchers outlined a set of 6 recommendations detailing what strategies medical institutions should implement in the event that medical resources become scarce during the COVID-19 pandemic.
Researchers from SITC suggested the use of anti-IL-6 agents on a compassionate basis to treat hospitalized critically ill patients infected with COVID-19.